Clinical Trial Update: Efficacy of Telmisartan and the Combination of Telmisartan and Ramipril in type1 Diabetes Patients With Nephropathy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating telmisartan alone and in combination with ramipril for diabetic nephropathy in type 1 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Type 1 Diabetes Mellitus

Drugs mentioned

• Ramipril (ramipril)
• Telmisartan (Telmisartan)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Diabetic Nephropathy | Phase 3 | Status: COMPLETED